BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 23628312)

  • 1. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y; Lu J; Hong K; Huang Y; Ma L
    Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
    Liu YQ; Lu J; Zhao L; Hou XF; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):605-10. PubMed ID: 26284394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH; Choi WS; Kwak C; Kim HH
    Urol Oncol; 2011; 29(4):383-7. PubMed ID: 19556154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience.
    Fang D; Xiong GY; Li XS; Chen XP; Zhang L; Yao L; He ZS; Zhou LQ
    J Formos Med Assoc; 2014 Nov; 113(11):820-7. PubMed ID: 24360737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy.
    Abe T; Shinohara N; Harabayashi T; Sazawa A; Akino T; Ishikawa S; Kubota K; Matsuno Y; Osawa T; Shibata T; Toyoda Y; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
    BJU Int; 2010 Apr; 105(8):1102-6. PubMed ID: 19725822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Nakajima Y; Oya M
    Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.
    Kusuda Y; Miyake H; Terakawa T; Kondo Y; Miura T; Fujisawa M
    Urol Oncol; 2013 Aug; 31(6):899-903. PubMed ID: 21824792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial.
    Ito A; Shintaku I; Satoh M; Ioritani N; Aizawa M; Tochigi T; Kawamura S; Aoki H; Numata I; Takeda A; Namiki S; Namima T; Ikeda Y; Kambe K; Kyan A; Ueno S; Orikasa K; Katoh S; Adachi H; Tokuyama S; Ishidoya S; Yamaguchi T; Arai Y
    J Clin Oncol; 2013 Apr; 31(11):1422-7. PubMed ID: 23460707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Zou L; Zhang L; Zhang H; Jiang H; Ding Q
    World J Urol; 2014 Apr; 32(2):565-70. PubMed ID: 24022234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
    Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
    Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
    Hirano D; Okada Y; Nagane Y; Satoh K; Mochida J; Yamanaka Y; Hirakata H; Yamaguchi K; Kawata N; Takahashi S; Henmi A
    Urol Int; 2012; 89(1):71-7. PubMed ID: 22677699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.